This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Randomized Controlled Trial

. 2007 Nov 24;370(9601):1740-2.

doi: 10.1016/S0140-6736(07)61480-9. Epub 2007 Oct 4.

HPV testing for primary cervical cancer screening

Guglielmo Ronco¹, Nereo Segnan

Affiliations

PMID: 17919717
DOI: 10.1016/S0140-6736(07)61480-9

Randomized Controlled Trial

HPV testing for primary cervical cancer screening

Guglielmo Ronco et al. Lancet. 2007.

. 2007 Nov 24;370(9601):1740-2.

doi: 10.1016/S0140-6736(07)61480-9. Epub 2007 Oct 4.

Authors

Guglielmo Ronco¹, Nereo Segnan

Affiliation

¹ Unit of Cancer Epidemiology, CPO Piemonte, Torino 10123, Italy. guglielmo.ronco@cpo.it

PMID: 17919717
DOI: 10.1016/S0140-6736(07)61480-9

No abstract available

PubMed Disclaimer

Comment on

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial.
Bulkmans NW, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJ, Bulk S, Voorhorst FJ, Verheijen RH, van Groningen K, Boon ME, Ruitinga W, van Ballegooijen M, Snijders PJ, Meijer CJ. Bulkmans NW, et al. Lancet. 2007 Nov 24;370(9601):1764-72. doi: 10.1016/S0140-6736(07)61450-0. Epub 2007 Oct 4. Lancet. 2007. PMID: 17919718 Clinical Trial.

Similar articles

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial.
Bulkmans NW, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJ, Bulk S, Voorhorst FJ, Verheijen RH, van Groningen K, Boon ME, Ruitinga W, van Ballegooijen M, Snijders PJ, Meijer CJ. Bulkmans NW, et al. Lancet. 2007 Nov 24;370(9601):1764-72. doi: 10.1016/S0140-6736(07)61450-0. Epub 2007 Oct 4. Lancet. 2007. PMID: 17919718 Clinical Trial.
[A study of cervical cancer screening algorithms].
Zhao FH, Zhang WH, Pan QJ, Zhang X, Chen W, Liu B, Ma JF, Hu SY, Qiao YL. Zhao FH, et al. Zhonghua Zhong Liu Za Zhi. 2010 Jun;32(6):420-4. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 20819481 Chinese.
Screening for cervical cancer and initial treatment of patients with abnormal results from papanicolaou testing.
Bundrick JB, Cook DA, Gostout BS. Bundrick JB, et al. Mayo Clin Proc. 2005 Aug;80(8):1063-8. doi: 10.4065/80.8.1063. Mayo Clin Proc. 2005. PMID: 16092586 Review.
[Current methods of diagnosis of uterine cervix precancer and cancer (a literature review)].
Podistov IuI, Laktionov KP, Petrovichev NN. Podistov IuI, et al. Klin Lab Diagn. 2003 Mar;(3):15-24. Klin Lab Diagn. 2003. PMID: 12715392 Review. Russian. No abstract available.
Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.
Safaeian M, Solomon D, Wacholder S, Schiffman M, Castle P. Safaeian M, et al. Obstet Gynecol. 2007 Jun;109(6):1325-31. doi: 10.1097/01.AOG.0000263461.71732.40. Obstet Gynecol. 2007. PMID: 17540804 Clinical Trial.

See all similar articles

Cited by

Demethoxycurcumin Inhibits In Vivo Growth of Xenograft Tumors of Human Cervical Cancer Cells.
Chueh FS, Lien JC, Chou YC, Huang WW, Huang YP, Huang JY, Kuo JY, Huang WN, Sheng SY, Tung HY, Chen HY, Peng SF. Chueh FS, et al. In Vivo. 2020 Sep-Oct;34(5):2469-2474. doi: 10.21873/invivo.12062. In Vivo. 2020. PMID: 32871774 Free PMC article.
Ormeloxifene nanotherapy for cervical cancer treatment.
Chauhan N, Maher DM, Hafeez BB, Mandil H, Singh MM, Yallapu MM, Jaggi M, Chauhan SC. Chauhan N, et al. Int J Nanomedicine. 2019 Sep 3;14:7107-7121. doi: 10.2147/IJN.S200944. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31564868 Free PMC article.
A triphenylethylene nonsteroidal SERM attenuates cervical cancer growth.
Chauhan N, Maher DM, Yallapu MM, B Hafeez B, Singh MM, Chauhan SC, Jaggi M. Chauhan N, et al. Sci Rep. 2019 Jul 29;9(1):10917. doi: 10.1038/s41598-019-46680-0. Sci Rep. 2019. PMID: 31358785 Free PMC article.
Major clinical research advances in gynecologic cancer in 2013.
Suh DH, Kim JW, Kang S, Kim HJ, Lee KH. Suh DH, et al. J Gynecol Oncol. 2014 Jul;25(3):236-48. doi: 10.3802/jgo.2014.25.3.236. Epub 2014 Jul 3. J Gynecol Oncol. 2014. PMID: 25045437 Free PMC article. Review.
Budget impact analysis of introducing digital breast tomosynthesis in breast cancer screening in Italy.
Djuric O, Deandrea S, Mantellini P, Sardanelli F, Venturelli F, Montemezzi S, Vecchio R, Bucchi L, Senore C, Giordano L, Paci E, Bonifacino A, Calabrese M, Caumo F, Degrassi F, Sassoli De' Bianchi P, Battisti F, Zappa M, Pattacini P, Campari C, Nitrosi A, Di Leo G, Frigerio A, Magni V, Fornasa F, Romanucci G, Falini P, Auzzi N, Armaroli P, Giorgi Rossi P; MAITA working group; Italian Breast Cancer Screening Guidelines working group. Djuric O, et al. Radiol Med. 2024 Sep;129(9):1288-1302. doi: 10.1007/s11547-024-01850-7. Epub 2024 Aug 20. Radiol Med. 2024. PMID: 39162938

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical